Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enalapril for Mitigation of Radiation Pneumonitis
NCT01754909Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Nov 2013
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of enalapril in radiation pneumonitis (RP), radiation fibrosis syndrome (RIF), sponsored by VA Office of Research & Development. Started Nov 2013; status: completed.
02
Drugs
enalapril
03
Conditions
radiation pneumonitis (RP)radiation fibrosis syndrome (RIF)
Beyond the preview
Go deeper on NCT01754909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01754909.